In this respect, the transcriptional repressor PARIS (ZNF746) was identified by our group in 20116 among several other co-substrates of PINK1 and parkin as a promising candidate to shed light on possible contributions of a defective mitochondrial biogenesis to PD pathogenesis. The gene discussed is PRKN; the disease is Parkinson disease.